AACR20: ctDNA shows promise for early detection and prevention of cancer

27 Apr 2020

Written by Rachel Jenkins, Future Science Group

Two studies, due to be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting I (27–28 April 2020), have suggested promising conclusions relating to the use of circulating tumor DNA (ctDNA) for early detection and prevention of cancer. Read the full summaries below. Is it possible to predict cancer and tissue of origin (TOO) using circulating free DNA (cfDNA)? Researchers from a multi-institute team, led by the Mayo Clinic Florida (FL, USA), have investigated a cfDNA test that has demonstrated the potential to predict multiple cancers and tissue of origin (TOO) ahead of histologic diagnosis. The results...